ArticleCureus2025
Chronic Idiopathic Recurrent Orbital Myositis in a Patient With Concomitant Late-Onset Hashimoto's Thyroid Eye Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 38-year-old female presented to a tertiary centre with a nine-year history of chronic recurrent isolated lateral rectus orbital myositis (OM). Initially, her condition responded to short courses of oral corticosteroids and orbital steroid injections, but it later became refractory, with an inability to taper off steroids. Concurrently, the patient developed a low-grade clinical activity score for bilateral thyroid eye disease (TED) due to Hashimoto's thyroiditis (HT). Although the active phase of TED resolved without significant sequelae, she continued to experience unilateral pain and extraocular muscle (EOM) motility restriction consistent with lateral rectus myositis. This report describes a rare case of chronic recurrent idiopathic OM overlapping with a concomitant bilateral TED associated with HT, which was successfully managed with rituximab immunosuppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.